Ketamine can reduce anxiety symptoms within hours of a single dose, making it one of the fastest-acting options available for mood and anxiety disorders. Most patients notice meaningful relief within the first 24 hours, with peak effects appearing 24 to 48 hours after treatment. That speed is remarkable compared to standard anti-anxiety medications like SSRIs, which typically take four to six weeks before any noticeable change.
What Happens in the First Hours
During a ketamine infusion, which usually lasts about 40 minutes, you won’t feel your anxiety lifting in real time. What you’re more likely to notice during the session itself are side effects: dizziness, a dreamlike or dissociative state, nausea, or visual disturbances. Some people describe it as feeling like they’re dreaming while awake. These effects are temporary and generally resolve within a couple of hours after the infusion ends.
The anxiety relief tends to emerge more clearly once the acute drug effects wear off. Many patients report a noticeable shift in their mood and worry levels within hours of that first session, sometimes by the end of the same day. The strongest improvements typically show up in the 24 to 48 hours following treatment. In studies of the nasal spray form (esketamine, sold as Spravato), the greatest separation from placebo appeared within just four hours of administration.
Why It Works So Much Faster Than SSRIs
Traditional anti-anxiety and antidepressant medications work by gradually adjusting serotonin levels in the brain. That process requires the brain to slowly adapt over weeks, which is why doctors tell you to wait four to six weeks before judging whether your medication is working. Many patients wait even longer, and a significant number never respond at all.
Ketamine takes a completely different route. It blocks a specific type of receptor involved in signaling between brain cells, which triggers a rapid burst of activity in neighboring neurons. That burst increases the brain’s ability to strengthen and build new connections between cells, a process called neuroplasticity. In animal studies, new connections (dendritic spines) form at the highest rate on the day after a ketamine dose. Some of these new connections stabilize into functional synapses within about four days. This rewiring effect is thought to restore communication in brain circuits that anxiety and depression have disrupted.
Ketamine also triggers the release of a key growth factor that supports neuron health and new connection formation. So rather than slowly nudging one chemical system over weeks, ketamine rapidly activates multiple pathways that reshape how brain cells talk to each other. That’s why the timeline is hours instead of weeks.
How Long the Relief Lasts
This is where expectations need adjusting. A single ketamine treatment produces fast relief, but it doesn’t last. In clinical studies, patients who responded to a single infusion typically relapsed within one to two weeks. One study found relapse occurring anywhere from 6 to 45 days after a course of treatment, with an average of about 19 days.
That’s why ketamine is almost never given as a one-time treatment. The standard approach involves an induction phase of six infusions, typically given three times a week over two weeks. After that initial course, patients who respond well move into maintenance treatments, often once a week for another month or longer. Over time, providers work with each patient to find the right interval, which for many people lands somewhere around every three to four days during active treatment. There’s no universal schedule; the benefits wear off at different rates for different people.
In one controlled trial published in the American Journal of Psychiatry, patients who completed six infusions and responded well received weekly maintenance infusions for four additional weeks. Even with repeated dosing, some patients relapse. In a study of 14 patients who received six infusions, all but one relapsed within two weeks of stopping treatment. The takeaway: ketamine works fast, but staying well usually requires ongoing sessions or a transition to other longer-term treatments.
What Treatment Actually Looks Like
If you pursue ketamine for anxiety, you’ll most likely receive it in one of two forms. Intravenous infusions are administered at specialized clinics, where you sit in a reclining chair for about 40 minutes while the drug is delivered through an IV at a dose well below what’s used for anesthesia. You’ll be monitored throughout and for a short period afterward. Plan on being at the clinic for about two hours total per session.
The nasal spray version, esketamine, is FDA-approved for treatment-resistant depression and is administered in a doctor’s office. You self-administer the spray under supervision, then stay for at least two hours of monitoring. You cannot drive for the rest of the day after either form of treatment.
Side effects during and shortly after a session commonly include dizziness, drowsiness, confusion, nausea, a dreamlike feeling, and sometimes visual disturbances like double vision. These typically fade within a few hours. Some people experience brief episodes of seeing or hearing things that aren’t there, or feeling detached from their surroundings. Clinics expect these reactions and monitor for them, which is why you can’t take ketamine at home for this purpose (with limited exceptions for some oral formulations prescribed off-label).
Who It Works Best For
Most of the clinical research on ketamine has focused on treatment-resistant depression rather than anxiety specifically, though the two conditions overlap heavily. Ketamine is generally considered when standard treatments have failed, not as a first-line option. If you’ve tried multiple medications without adequate relief, or if your anxiety is severe enough that waiting weeks for an SSRI to kick in feels untenable, ketamine’s rapid onset becomes especially relevant.
The speed of relief is also significant for people experiencing acute psychiatric crises. Studies have shown ketamine reduces suicidal thinking within hours, a timeline no other available medication can match. For someone in that situation, the difference between hours and weeks is not just a convenience; it’s potentially lifesaving.
Not everyone responds to ketamine. Across studies, response rates vary, and there’s currently no reliable way to predict who will benefit before trying it. The cost can also be a barrier, as many insurance plans don’t cover IV ketamine infusions (though esketamine has broader insurance coverage). A typical induction course of six infusions can run several thousand dollars out of pocket.